Page 434 - 先天性心脏病的导管术:从婴幼儿期到成人期
P. 434

416                                       先天性心脏病的导管术:从婴幼儿期到成人期



             参考文献

             [1]  Chessa M, Carminati M, Cao QL, Butera G, Giusti S, Bini RM, Hijazi ZM. Transcathe-
                 ter closure of congenital and acquired muscular ventricular septal defects using the Am-
                 platzer device. J Invasive Cardiol. 2002;14:322-7.
             [2]  Holzer R, Balzer D, Qi-Ling C, Lock K, Hijazi ZM, Amplatzer Muscular Ventricu-

                 lar Septal Defect Investigators. Device closure of muscular ventricular septal defects
                 using the Amplatzer muscular ventricular septal defect occluder. J Am Coll Cardiol.
                 2004;43:1257-63.
             [3]  Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, Peuster M,

                 Piechaud JF, Santoro G, Sievert H, Spadoni I, Walsh K. Transcatheter closure of con-
                 genital ventricular septal defects: results of the European Registry. Investigators of the
                 European VSD registry. Eur Heart J. 2007;28(19):2361-8.
             [4]  Arora R, Trehan V, Thakur AK, Mehta V, Sengupta PP, Nigam N. Transcatheter closure

                 of congenital muscular ventricular septal defect. J Interv Cardiol. 2004;17:109-15.
             [5]  Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza L. Transcatheter clo-
                 sure of congenital ventricular septal defects with Amplatzer occluders. Am J Cardiol.
                 2005;96(12A):52L-8L.

             [6]  Szkutnik M, Qureshi SA, Kusa J, Rosenthal E, Bialkowski J. Use of the Amplatzer mus-
                 cular ventricular septal defect occluder for closure of perimembranous ventricular septal
                 defects. Heart. 2007;93(3):355-8.
             [7]  Bacha EA, Cao QL, Galantowicz ME, Cheatham JP, Fleishman CE, Weinstein SW,

                 Becker PA, Hill SL, Koenig P, Alboliras E, Abdulla R, Starr JP, Hijazi ZM. Multicenter
                 experience with periventricular device closure of muscular ventricular septal defects.
                 Pediatr Cardiol. 2005;26:169-75.
             [8]  Diab KA, Cao QL, Mora BN, Hijazi ZM. Device closure of muscular ventricular septal

                 defects in infants less than one year of age using the Amplatzer devices: feasibility and
                 outcome. Cath Cardiovasc Interv. 2007;70:90-7.
             [9]  Dua JS, Carminati M, Lucente M, Piazza L, Chessa M, Negura D, Bussadori C, Saliba Z,
                 Butera G. Transcatheter closure of post-surgical residual ventricular septal defects: early

                 and mid-term results. Cath Cardiovasc Interv. 2010;75:246-55.
             [10] Landman G, Kipps A, Moore P, Teitel D, Meadows J. Outcomes of a modified approach
                 to transcatheter closure of perimembranous ventricular septal defects. Catheter Cardio-
   429   430   431   432   433   434   435   436   437   438   439